Richard O. Day
Richard O. Day
Professor of Clinical Pharmacology, University of New South Wales and St Vincent's Hospital, Sydney
Verified email at unsw.edu.au - Homepage
Title
Cited by
Cited by
Year
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
C Bombardier, L Laine, A Reicin, D Shapiro, R Burgos-Vargas, B Davis, ...
New England Journal of Medicine 343 (21), 1520-1528, 2000
50532000
Nonsteroidal antiinflammatory drugs—differences and similarities
PM Brooks, RO Day
New England Journal of Medicine 324 (24), 1716-1725, 1991
11971991
Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
AG Johnson, TV Nguyen, RO Day
Annals of internal medicine 121 (4), 289-300, 1994
9231994
Clinical pharmacokinetics of metformin
GG Graham, J Punt, M Arora, RO Day, MP Doogue, JK Duong, TJ Furlong, ...
Clinical pharmacokinetics 50 (2), 81-98, 2011
8782011
Association of interruptions with an increased risk and severity of medication administration errors
JI Westbrook, A Woods, MI Rob, W Dunsmuir, RO Day
Archives of Internal medicine 170 (8), 683-690, 2010
7502010
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
GC Machado, CG Maher, PH Ferreira, MB Pinheiro, CWC Lin, RO Day, ...
bmj 350, 2015
4522015
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings
GG Graham, MJ Davies, RO Day, A Mohamudally, KF Scott
Inflammopharmacology 21 (3), 201-232, 2013
4392013
Clinical pharmacokinetics and pharmacodynamics of celecoxib
NM Davies, AJ McLachlan, RO Day, KM Williams
Clinical pharmacokinetics 38 (3), 225-242, 2000
4392000
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
X Jiang, KM Williams, WS Liauw, AJ Ammit, BD Roufogalis, CC Duke, ...
British journal of clinical pharmacology 57 (5), 592-599, 2004
3492004
CareTrack: assessing the appropriateness of health care delivery in Australia
WB Runciman, TD Hunt, NA Hannaford, PD Hibbert, JI Westbrook, ...
Medical Journal of Australia 197 (2), 100-105, 2012
3432012
A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis
R Day, B Morrison, A Luza, O Castaneda, A Strusberg, M Nahir, ...
Archives of internal medicine 160 (12), 1781-1787, 2000
3382000
Stereoselective disposition of ibuprofen enantiomers in man
EJD Lee, KM Williams, R Day, G Graham, D Champion
British journal of clinical pharmacology 58 (7), S759-S764, 2004
330*2004
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
P Brooks, P Emery, JF Evans, H Fenner, CJ Hawkey, C Patrono, J Smolen, ...
Rheumatology 38 (8), 779, 1999
3271999
Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review
MH Reckmann, JI Westbrook, Y Koh, C Lo, RO Day
Journal of the American Medical Informatics Association 16 (5), 613-623, 2009
3172009
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial
CM Williams, CG Maher, J Latimer, AJ McLachlan, MJ Hancock, RO Day, ...
The Lancet 384 (9954), 1586-1596, 2014
2652014
Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
X Jiang, KM Williams, WS Liauw, AJ Ammit, BD Roufogalis, CC Duke, ...
British journal of clinical pharmacology 59 (4), 425-432, 2005
2542005
Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis
CA Shaheed, CG Maher, KA Williams, R Day, AJ McLachlan
JAMA internal medicine 176 (7), 958-968, 2016
2492016
A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?
MHH Lee, GG Graham, KM Williams, RO Day
Drug Safety 31 (8), 643-665, 2008
2282008
Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial
MJ Hancock, CG Maher, J Latimer, AJ McLachlan, CW Cooper, RO Day, ...
The Lancet 370 (9599), 1638-1643, 2007
2252007
[Tolerability of paracetamol]
GG Graham, KF Scott, RO Day
Drugs 63, 43, 2003
1972003
The system can't perform the operation now. Try again later.
Articles 1–20